Analyst Charles Rhyee of TD Cowen maintained a Buy rating on Cencora (COR – Research Report), with a price target of $288.00. Charles ...

Upon closing, the acquisition of RCA is expected to be approximately $0.35 accretive, net of estimated financing costs, to ...

SALARIES: All costs associated with fielding a staff, including salary, payroll taxes, payroll processing fees, health insurance, and other benefits. STRATEGY & RESEARCH: Spending on polling and ...

CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced a definitive agreement to acquire Retina Consultants of America ...

Cencora ( NYSE:COR ) Full Year 2024 Results Key Financial Results Revenue: US$294.0b (up 12% from FY 2023). Net income... Cencora, Inc.'s ( NYSE:COR ) dividend will be increasing from last year's ...

Cencora's Q4 sales rose 14.7% to $79.1 billion, exceeding $77.65 billion consensus; adjusted EPS increased 16.8% to $3.34. The Retina Consultants of America deal will add nearly 300 retina ...

the benefits of the proposed transaction, future opportunities for Cencora and RCA and any other statements regarding Cencora’s or RCA’s future operations, financial or operating results ...

However, prior to this announcement, Cencora's dividend was comfortably covered by both cash flow and earnings. This means that most of its earnings are being retained to grow the business.

CONSHOHOCKEN, Pa. — CONSHOHOCKEN, Pa. — Cencora, Inc. (COR) on Wednesday reported fiscal fourth-quarter net income of $3.4 million. On a per-share basis, the Conshohocken, Pennsylvania-based ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

(RTTNews) - Cencora, Inc. (COR), a pharma company, announced on Wednesday that it has inked a deal to acquire Retina Consultants of America or RCA, a management services organization of retina ...